A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review-Reference-Cited by-同舟云学术

A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review

Published:2024-08-19 Issue: Volume: Page:
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Ferreira-da-Silva Renato^ORCID,Reis-Pardal Joana^ORCID,Pinto Manuela^ORCID,Monteiro-Soares Matilde^ORCID,Sousa-Pinto Bernardo^ORCID,Morato Manuela^ORCID,Polónia Jorge Junqueira^ORCID,Ribeiro-Vaz Inês^ORCID

Funder

Fundação para a Ciência e a Tecnologia

Universidade do Porto

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40264-024-01470-0.pdf

Reference85 articles.

1. Avorn J. In defense of pharmacoepidemiology—embracing the yin and yang of drug research. N Engl J Med. 2007;357(22):2219–21. https://doi.org/10.1056/NEJMp0706892.

2. Garattini S, Chalmers I. Patients and the public deserve big changes in evaluation of drugs. BMJ. 2009;338:1025. https://doi.org/10.1136/bmj.b1025.

3. Alomar M, Tawfiq AM, Hassan N, Palaian S. Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future. Ther Adv Drug Saf. 2020;11:2042098620938595. https://doi.org/10.1177/2042098620938595.

4. Torre C, Cary M, Borges FC, et al. Intensive monitoring studies for assessing medicines: a systematic review. Front Med (Lausanne). 2019;6:147. https://doi.org/10.3389/fmed.2019.00147.

5. Vázquez-Alvarez AO, Brennan-Bourdon LM, Rincón-Sánchez AR, Islas-Carbajal MC, Huerta-Olvera SG. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients. BMC Pharmacol Toxicol. 2017;18(1):79. https://doi.org/10.1186/s40360-017-0186-x.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Event monitoring is predominant pharmacovigilance strategy for antivirals;Reactions Weekly;2024-08-31